PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 246776

Some recent developments in quantum organic chemistry.

M J Dewar
View original source ↗Export metadata ↓

Abstract

The present status of attempted to calculate chemical behaviour in organic chemistry in a quantitative manner is reviewed. Results given by a new semiempirical SCF MO method (MNDO) are reported. Specific topics discussed include the calculation of molecular vibration frequencies, entropies, specific heats, entropies of activation, kinetic isotope effects, and the mechanisms of several organic reactions, in particular the Diels-Alder reaction and the Cope rearrangment.

Explore related subjects

Chemistry, OrganicDeuteriumMagnetic Resonance SpectroscopyOrganic Chemistry PhenomenaQuantum TheoryThermodynamicsVibrationJournal ArticleResearch Support, U.S. Gov't, Non-P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M J Dewar. 1978. Some recent developments in quantum organic chemistry.. https://doi.org/10.1002/9780470720349.ch8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

The importance of stereochemistry in drug action and disposition.

Many biologically active synthetic drugs contain chiral centers, although they are used as racemic mixtures. Enantiomers are hard to distinguish in the chemical laboratory but are readily discriminated in the body and differ in their biological activities and disposition. The pharmacokinetic profiles of enantiomers can be variable, especially for drugs with a first-pass effect and enantioselective pharmacokinetic monitoring should be carried out. Ultimately, whether to exploit a racemate or a single enantiomer in therapy is a multi-faceted decision to which drug disposition data have important contributions to make.

Chemistry, Organic↗
PubMed1992

Stereochemistry and bioequivalence.

Despite the fact that many important drugs are chiral, for a variety of reasons they are marketed as racemates (i.e., an equal proportion of two enantiomers). Although enantiomers of racemic drugs often differ from one another in their pharmacodynamic and pharmacokinetic properties, bioequivalence assessments are made using nonstereospecific assays. Such an approach may provide a poor assessment of therapeutic equality. This can be true particularly for drugs with complicated pharmacokinetics and those that exhibit extensive stereoselectivity in their disposition kinetics. Accordingly, examples of bioequivalence studies based on stereospecific assays have started to appear in the literature. Fortunately, facile stereospecific assays have become available in the last several years for many drugs. Consequently, regulatory agencies have started to take the issue of stereochemistry into consideration in the assessment of bioequivalence, particularly from the standpoint of generic substitution.

Chemistry, Organic↗